CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
CANADA
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Masco Group now a major stakeholder of Swedish company, KeyPlants AB

Masco Group now a major stakeholder...

How AIin Biotech and PharmaceuticalImpacts Drug Discovery

How AIin Biotech and...

Specialized Services: A New Paradigm in Therapeutics

Specialized Services: A New Paradigm...

Setting A Culture for Digital Transformation in the Biopharmaceutical Industry

Setting A Culture for Digital...

The 7 TIPS for a Successful Master Data Migration and Ongoing Data Quality Management

The 7 TIPS for a Successful Master...

The Challenges Of Bringing Phytocannabinoid Plant-Based Medicines To Market

The Challenges Of Bringing...

Take Advantage of Technology in Infection Prevention!

Take Advantage of Technology in...

Digital Innovation

Digital Innovation

Masco Group now a major stakeholder of Swedish company, KeyPlants AB

Masco Group now a major stakeholder...

How AIin Biotech and PharmaceuticalImpacts Drug Discovery

How AIin Biotech and...

Specialized Services: A New Paradigm in Therapeutics

Specialized Services: A New Paradigm...

Setting A Culture for Digital Transformation in the Biopharmaceutical Industry

Setting A Culture for Digital...

The 7 TIPS for a Successful Master Data Migration and Ongoing Data Quality Management

The 7 TIPS for a Successful Master...

The Challenges Of Bringing Phytocannabinoid Plant-Based Medicines To Market

The Challenges Of Bringing...

Take Advantage of Technology in Infection Prevention!

Take Advantage of Technology in...

Digital Innovation

Digital Innovation

Myriad Genetics And Epic Join Forces To Expand Access To Genetic Testing For More Patients

Life Sciences Review | Monday, July 04, 2022
Tweet

The partnership between Myriad Genetics and Epic will facilitate the expansion of Myriad's customer-centric, technology-enabled commercial capabilities through over 600 EHR integrations.


Fremont, CA: “Our collaboration with Epic reflects our strategy to partner with other healthcare industry leaders so we can advance precision medicine together. Increasing access to genetic insights and integrating our tests into Epic's vast network of healthcare systems represents a significant step forward to better serve patients and healthcare providers," comments Paul J. Diaz, president, and CEO, of Myriad Genetics. Myriad Genetics, an industry leader in genetic testing and precision medicine, has collaborated with Epic, the top healthcare software company, to connect Myriad's comprehensive array of genetic tests with Epic's vast network of 600,000 clinicians and more than 250 million patients.


The connection enables a smooth, end-to-end workflow solution for healthcare providers to order Myriad testing and evaluate findings without additional stages or manual ordering. Epic facilitates the secure transmission of patient information across healthcare organizations.


 


With the ability to evaluate pertinent health information, order tests, and receive findings natively within Epic, doctors will have access to the genetic insights and related information necessary to improve health outcomes and the patient experience. In addition, patients will have easy access to their Myriad test results and other health information via their EHR site.


As part of its transformation and growth strategy, Myriad is emphasizing the development of customer-centric, technology-enabled products that simplify genetic testing for patients and physicians. With the recent introduction of Myriads Precise Oncology Solutions, providers may now submit a single order for several Myriad tests and obtain rapid results via a centralized web platform. Now, through the agreement with Epic, Myriad is expanding its efforts to enable clinicians and health organizations to gain faster and more convenient access to genetic testing within their existing platform.


“Genetic testing and precision medicine save lives,” states Alan Hutchison, vice president of Population Health at Epic. “Through this relationship, were bringing genetic insights to the point of care at scale, giving providers and patients the information they need to make more timely, informed decisions.”


Weekly Brief

loading
> <
  • Therapeutics 2022

    Top Vendors

    Current Issue
  • Life Science Compliance 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • Therapeutics 2022

    Top Vendors

    Current Issue
  • Life Science Compliance 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue

Read Also

Best Practices to Boost Life Sciences Content Marketing

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Major Trends of HEOR in the Healthcare Industry

Sustainable Laboratory Techniques for a Sustainable Future

Applications of Proteomics in Medicine

Contract Research Organizations: What You Need to Know

Marketing Opportunities in the Life Science to Monitor in 2022

Ginkgo Enters Into A Definitive Agreement To Acquire Zymergen

Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/myriad-genetics-and-epic-join-forces-to-expand-access-to-genetic-testing-for-more-patients--nwid-864.html